The European Stroke Organisation (ESO) guidelines on Moyamoya Angiopathy (MMA),
developed according to ESO standard operating procedure and Grading of …

Background Pediatric stroke, which is unique in that it represents a static insult to a
developing brain, often leads to long-term neurological disability. Neuroplasticity in infants …

Epilepsy's impact on cardiovascular function and autonomic regulation, including heart-rate
variability, is complex and may contribute to sudden unexpected death in epilepsy (SUDEP) …

Introduction Moyamoya disease (MMD) is a life-threatening condition characterized by
stenosis of intracranial arteries. Despite the frequency and the impact of psychiatric …

Background Moyamoya disease (MMD) is a rare disorder causing ischemic and
hemorrhagic juvenile stroke. It is associated with the founder susceptibility variant p …

Neurofibromatosis type 1 (NF1) is a multisystemic neurocutaneous disease caused by a
heterozygous mutation of the NF1 gene that encodes neurofibromin. Complications include …

Background and purpose: The aim of our study is to present, for the first time, the clinical,
radiological, and neurocognitive characteristics of Greek adult patients with Moyamoya …

Moyamoya disease (MMD) is considered a primary disorder of an unknown etiology. In
contrast, Moyamoya syndrome (MMS) refers to MMD associated with other underlying …

Epidemiology, causes, and morbidities of stroke in the young Page 1 CURRENT OPINION
Epidemiology, causes, and morbidities of stroke in the young Anna M. Janasa, Megan Barryb …

Background Moyamoya disease (MMD) is a significant cause of childhood stroke and
transient ischemic attacks (TIAs). This study aimed to assess the safety and efficacy of …